XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (60,599) $ (73,285)
Adjustments to reconcile net loss to cash flows used in operating activities:    
Depreciation and amortization of property and equipment 10,131 10,603
Amortization of intangible assets 39,077 43,725
Amortization of debt issuance costs and original issue discount 4,137 2,517
Amortization of accumulated other comprehensive gain related to interest rate swap (8,196) (3,818)
Stock-based compensation 12,061 16,914
Deferred income taxes (14,614) (3,617)
Gain on sale of swap   (7,301)
Change in fair value of warrant liability 292 (444)
Change in fair value of preferred stock liability 8,091 (572)
Dividends accrued on preferred stock liability 2,743 2,573
Payment of dividends accrued on preferred stock liability (6,686)  
Foreign currency exchange losses 1,357 1,174
Changes in operating assets and liabilities:    
Accounts receivable 18,896 31,345
Inventory (1,630) (4,327)
Other operating assets 9,456 27,785
Accounts payable (7,580) (22,276)
Accrued expenses and other long-term liabilities 1,624 (16,255)
Deferred revenue (20,087) (7,793)
Net cash used in operating activities (11,527) (3,052)
Cash flows from investing activities:    
Purchases of property and equipment (14,428) (6,620)
Purchases of software licenses (462)  
Net cash used in investing activities (14,890) (6,620)
Cash flows from financing activities:    
Borrowings under revolving line of credit 44,106 67,000
Principal payments on revolving line of credit (44,106) (57,000)
Proceeds from issuance of term debt 342,300  
Principal payments of term debt (236,270) (90,044)
Payment of debt issuance costs (5,985) (1,572)
Proceeds from issuance of preferred stock and warrant liabilities   53,350
Payment of preferred stock liability (56,850)  
Proceeds from the exercise of stock options 17 15
Payment of tax obligations related to vested stock awards and units (3,035) (3,912)
Net cash provided by (used in) financing activities 40,177 (32,163)
Effect of exchange rate changes on cash and cash equivalents (297) (926)
Net increase (decrease) in cash and cash equivalents 13,463 (42,761)
Cash, cash equivalents and restricted cash, beginning of year 26,630 67,262
Cash, cash equivalents and restricted cash, end of period 40,093 24,501
Supplemental disclosure of cash flow information:    
Interest paid 22,851 18,606
Income taxes paid 12,807 9,721
Income tax refunds received 1,294 1,160
Supplemental disclosure of non-cash investing activities:    
Capital expenditures incurred, but not yet paid 3,946 2,505
Inventory transfers to property and equipment 1,297 1,524
Supplemental disclosure of non-cash financing activities:    
Fair value of vested restricted and performance-based stock grants $ 10,454 $ 13,454